Literature DB >> 28612244

Cerebral venous sinus thrombosis in Behçet's disease: a retrospective case-control study.

Jing Shi1, Xinxiang Huang2, Guohua Li3, Li Wang1, Jinjing Liu1, Yan Xu4, Xiaofeng Zeng1, Wenjie Zheng5.   

Abstract

The objective of the study is to investigate the clinical features of Behçet's disease (BD) complicated with cerebral venous sinus thrombosis (CVST). We retrospectively analyzed the clinical features of age- and gender-matched BD patients with and without CVST. Of the 840 BD patients enrolled, 21 (2.5%, 11 female, mean age 30.3 ± 9.5) were diagnosed as CVST. Eighteen patients (85.7%) developed neurologic manifestations after BD onset, with an average interval of 47.6 months (SD 36.1). Onset of neurologic symptoms was mostly progressive (89.5%), with headache (95.2%) being the most common symptom. Intracranial hypertension occurred in 17 cases (89.5%). Thrombosis was detected mostly in transverse (71.4%) and superior sagittal (66.7%) sinuses, with more frequently (66.7%) dual or multiple sinuses involved. In addition, extra cranial thrombosis was presented in 11 cases. Cerebral infarction was presented in four cases. Compared with BD patients without CVST, the prevalence of extra cranial vascular involvement (52.4 versus 20.6%; P = 0.005) and BDCAF 2006 score (3.7 ± 1.4 versus 1.8 ± 1.3; P = 1.7863 × 10-7) was higher in BD patients with CVST. During a median 7-month follow-up (range 0.3-88.8 months), 18 patients (85.7%) achieved remission following glucocorticoid, immunosuppressant therapy, anticoagulants, and dehydration, although 3 patients experienced (14.3%) flare. No death was reported. CVST is rare complication of BD and predominately progressively developed in active BD and after BD onset. It typically features intracranial hypertension syndrome and is frequently complicated with extra cranial thrombosis; thus, systemic thrombus screening is highly recommended. Promptly, diagnosis and aggressive treatment are keys to improve the prognosis.

Entities:  

Keywords:  Behçet’s disease; Cerebral venous sinus; Thrombosis; Vasculitis

Mesh:

Substances:

Year:  2017        PMID: 28612244     DOI: 10.1007/s10067-017-3718-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  34 in total

Review 1.  Current concepts in the etiology and treatment of Behçet disease.

Authors:  Cem Evereklioglu
Journal:  Surv Ophthalmol       Date:  2005 Jul-Aug       Impact factor: 6.048

Review 2.  Cerebral venous thrombosis: an update.

Authors:  Marie-Germaine Bousser; José M Ferro
Journal:  Lancet Neurol       Date:  2007-02       Impact factor: 44.182

3.  EULAR recommendations for the management of Behçet disease.

Authors:  G Hatemi; A Silman; D Bang; B Bodaghi; A M Chamberlain; A Gul; M H Houman; I Kötter; I Olivieri; C Salvarani; P P Sfikakis; A Siva; M R Stanford; N Stübiger; S Yurdakul; H Yazici
Journal:  Ann Rheum Dis       Date:  2008-01-31       Impact factor: 19.103

Review 4.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

5.  Papilledema caused by cerebral venous sinus thrombosis in a patient with Behçet disease.

Authors:  Ali Ekrem Aydin; Ozgul Gunduz; Ismail Sari; Ali Osman Saatci; Erkan Yilmaz; Nurullah Akkoc
Journal:  J Clin Rheumatol       Date:  2013-01       Impact factor: 3.517

Review 6.  Major vessel involvement in Behçet's disease: an update.

Authors:  Kenneth T Calamia; Michael Schirmer; Melike Melikoglu
Journal:  Curr Opin Rheumatol       Date:  2011-01       Impact factor: 5.006

7.  Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.

Authors:  Gerard Espinosa; Josep Font; Dolors Tàssies; Antonio Vidaller; Ramon Deulofeu; Alfons López-Soto; Ricard Cervera; Antoni Ordinas; Miguel Ingelmo; Joan-Carles Reverter
Journal:  Am J Med       Date:  2002-01       Impact factor: 4.965

8.  Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease.

Authors:  S Buldanlioglu; S Turkmen; H B Ayabakan; N Yenice; M Vardar; S Dogan; E Mercan
Journal:  Br J Dermatol       Date:  2005-09       Impact factor: 9.302

9.  Long-term prognosis in cerebral venous thrombosis. Follow-up of 77 patients.

Authors:  M Preter; C Tzourio; A Ameri; M G Bousser
Journal:  Stroke       Date:  1996-02       Impact factor: 7.914

10.  Behçet's disease complicated with thrombosis: a report of 93 Chinese cases.

Authors:  Xiuhua Wu; Guohua Li; Xinxiang Huang; Li Wang; Wanli Liu; Yan Zhao; Wenjie Zheng
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

View more
  7 in total

Review 1.  Arterial and venous involvement in Behçet's syndrome: a narrative review.

Authors:  Neera Toledo-Samaniego; Crhistian Mario Oblitas; Eduardo Peñaloza-Martínez; Jorge Del-Toro-Cervera; Luis Antonio Alvarez-Sala-Walther; Pablo Demelo-Rodríguez; Francisco Galeano-Valle
Journal:  J Thromb Thrombolysis       Date:  2022-02-19       Impact factor: 2.300

2.  Neuro-Behcet's syndrome: Case report and literature review.

Authors:  Brian Peine; Christian Figueroa; Natasha Robinette
Journal:  Radiol Case Rep       Date:  2022-06-21

Review 3.  Vascular Behçet's syndrome: an update.

Authors:  Giacomo Emmi; Alessandra Bettiol; Elena Silvestri; Gerardo Di Scala; Matteo Becatti; Claudia Fiorillo; Domenico Prisco
Journal:  Intern Emerg Med       Date:  2018-11-29       Impact factor: 3.397

4.  Cerebral sinovenous thrombosis in children: A single-center experience.

Authors:  İpek Dokurel Çetin; Cenk Eraslan; Erdem Şimşek; Seda Kanmaz; Hepsen Mine Serin; Deniz Yılmaz Karapınar; Sanem Keskin Yılmaz; Gül Aktan; Hasan Tekgül; Sarenur Gökben
Journal:  Turk Arch Pediatr       Date:  2021-05-01

5.  Simultaneous Presentation of Uveitic Disc Edema and Papilledema in an Adult.

Authors:  Chase A Liaboe; Michael S Lee; Justin J Y Yamanuha
Journal:  Case Rep Ophthalmol Med       Date:  2020-07-08

Review 6.  Treating the Different Phenotypes of Behçet's Syndrome.

Authors:  Alessandra Bettiol; Gulen Hatemi; Lorenzo Vannozzi; Alessandro Barilaro; Domenico Prisco; Giacomo Emmi
Journal:  Front Immunol       Date:  2019-12-06       Impact factor: 7.561

7.  Clinical characteristics, inflammation and coagulation status in patients with immunological disease-related chronic cerebrospinal venous insufficiency.

Authors:  Si-Ying Song; Duo Lan; Xiao-Qin Wu; Yu-Chuan Ding; Xun-Ming Ji; Ran Meng
Journal:  Ann Transl Med       Date:  2021-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.